Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D001379:Azathioprine / Q000008:administration & dosage; D001792:Blood Platelets / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000494:pharmacology*; D004285:Dogs; D004357:Drug Synergism; D006084:Graft Rejection; D006648:Histocompatibility; D016030:Kidney Transplantation; D008722:Methods; D011241:Prednisone / Q000494:pharmacology*; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000925:Anticoagulants; D004176:Dipyridamole; D001379:Azathioprine; D001241:Aspirin; D011241:Prednisone